Big Tech stocks are treading water after $1 trillion sell-off week

Big Tech stocks are treading water after  trillion sell-off week


Big Tech stocks were treading water in premarket trading on Monday, after a bruising week that saw more than $1 trillion wiped from their market caps.

As of 6:40 a.m. ET, Oracle was up 1.6% and Microsoft had edged 0.8% higher. Meta was down 0.2% and Amazon was flat. Alphabet fell 0.5% and Nvidia was down around 0.9% after rebounding 7.9% on Friday.

The market grew jittery after expenditure outlooks continued to shoot through the roof in Big Tech earnings last week, as companies doubled down on AI bets.

Amazon, Alphabet, Microsoft and Meta reported a combined capital expenditure of about $120 billion in the fourth quarter alone. The figure could approach $700 billion in 2026, higher than the gross domestic product of countries like the United Arab Emirates, Singapore and Israel.

Jim Reid, head of global macro research at Deutsche Bank, wrote in a Monday note that last week was the worst for the “Magnificent 7” stocks since April, when U.S. tariffs plunged markets into crisis and the stocks fell 4.66%.

Nvidia CEO Jensen Huang: AI is going to fundamentally change how we compute everything

Signs of recovery were on show as the markets closed last week, with Magnificent 7 stocks rising 0.45% on Friday, despite Amazon falling 5.55%, Reid said.

Cloud companies’ growing margins come alongside “potential stock volatility” amid macro headwinds, said Justin Post, a research analyst at Bank of America Securities, in a note on Monday.

“But management teams seem confident in their ability to forecast demand and that capacity will be fully utilized in 2026,” he added.

The markets reacted negatively to Amazon and Alphabet’s capex guidance being “well above” consensus expectations, said David Lefkowitz, CIO head of US equities at UBS Financial Services on Friday, adding this “overshadowed stronger-than-expected cloud growth for both companies.”

Nvidia CEO Jensen Huang told CNBC’s “Halftime Report” on Friday that the tech industry’s surging capital expenditures for AI infrastructure were justified, given the “sky high” demand for computing power.

Analysts predict room to grow for hyperscaler capex.

“As monthly tokens processed grows exponentially, aggregate cloud revenue for GCP/AWS/Azure accelerates, data center commitments expand, and data center component suppliers highlight accelerating demand, we believe there will continue to be upward pressure on hyperscaler capex estimates,” Morgan Stanley said in a note on Monday morning.



Source

Sam Altman touts ChatGPT’s reaccelerating growth to employees as OpenAI closes in on 0 billion funding
World

Sam Altman touts ChatGPT’s reaccelerating growth to employees as OpenAI closes in on $100 billion funding

As OpenAI faces intensifying pressure from rival Anthropic’s improved coding tools, CEO Sam Altman is telling employees and investors that his company is seeing its share of momentum. Altman told OpenAI employees on Friday that ChatGPT, the company’s popular artificial intelligence chatbot, is “back to exceeding 10% monthly growth,” according to an internal Slack message […]

Read More
Databricks completes  billion funding round at 4 billion valuation
World

Databricks completes $5 billion funding round at $134 billion valuation

Ali Ghodsi, co-founder and CEO of Databricks. Databricks Databricks said Monday it has raised $5 billion in funding and $2 billion in new debt capacity at a $134 billion valuation. The privately held data analytics software company also said that its annualized revenue exceeded $5.4 billion for the January quarter, up 65% year over year, […]

Read More
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections
World

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. Tom Little | Reuters Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity pill and injections in […]

Read More